MBR Health collaborates with researchers, institutions and industry partners across the clinical research ecosystem. Whether supporting sponsor-led trials or investigator-initiated studies, our team provides comprehensive imaging, scientific expertise and regulatory support.
MBR Health is built for both clinical care and research innovation, with the infrastructure, expertise and collaborative ethos to support studies that make a difference.
The clinical research services described on this page are intended for clinicians, researchers, academic institutions, trial sponsors and industry partners seeking imaging and scientific support for clinical research programs. This page is not intended as a source of medical advice for patients. We recommend speaking with your GP or treating specialist in the first instance to determine whether research participation is appropriate for your individual situation.
MBR Health is home to some of Australia's leading modality experts in their respective fields, led by Dr Zane Sherif, Principal Radiologist, and Mr Ben Kennedy, Director of MRI and Clinical Research, supported by a dedicated team of senior clinical specialists.
Our Philips Ingenia Elition X 3T MRI scanner and NATA-accredited facility are built for both comprehensive clinical care and research innovation.
Comprehensive clinical trial support with proven expertise in imaging endpoints and specialised reporting standards.
All R&D staff hold active Good Clinical Practice certification, ensuring regulatory compliance across every study we support.
We build strong partnerships with academia, industry and clinician-scientists, approaching every collaboration with rigor, transparency and shared scientific purpose.
Capable of supporting both conventional and advanced imaging work ups.
Experienced in clinical trial imaging workflows and systems.
Secure storage and management of research imaging data.
Disease response reporting (e.g. RECIST) on request.
MBR Health supports clinical research across diagnostic imaging and regenerative medicine. Select your area below to understand how we can support your trial, study or research programme.
For institutions who carry our clinical trials on behalf of pharmaceutical or medical device companies, we are proud to offer the following research services:
Imaging Core Lab Services
Regulatory & Compliance
Specialised Disease Reporting
Ideal for clinician-scientists and higher-degree researchers seeking support for novel clinical questions, exploring emerging observations or correlating clinical trends. Services include:
We support universities, clinicians, trial sponsors and individual investigators across diagnostic imaging and regenerative medicine research. If you are a patient seeking exploratory regenerative pathways, please refer to our Regenerative Medicine and Chronic Disease pages.
If you are interested in participating in clinical research at MBR Health, we welcome your enquiry. Please contact our research team to discuss current and upcoming research programs and whether participation may be appropriate for your situation.
If you are a current research participant at a local study site, please speak with your trial coordinator about whether any of your required imaging can be performed at MBR Health. Our NATA-accredited facility, GCP-certified team and specialist imaging infrastructure are available to support a broad range of clinical trial imaging requirements.
Our research-grade imaging suite, including 3T MRI, Spectral CT, ultrasound and DEXA, is flexible to study needs and capable of supporting both conventional imaging protocols and bespoke custom approaches for novel research applications.
Meeting the highest standards of laboratory and imaging accreditation in Australia.
All R&D staff hold active Good Clinical Practice certification ensuring regulatory compliance across every study.
Working with leading global imaging technology partners on next-generation spectral CT development.
Across oncology, opportunistic health assessment, breast imaging and dose reduction programs.
Every protocol developed at MBR Health is validated through direct clinical application and real-world patient care.